Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Vaccines Inc, Us HealthfiledCriticalTakeda Vaccines Inc
Publication of AR113831A1publicationCriticalpatent/AR113831A1/en
Métodos para desactivar un virus de Zika que pueden ser usados en vacunas y composiciones inmunogénicas. Además, un método para determinar que se haya completado la desactivación de una preparación de arbovirus.Methods to inactivate a Zika virus that can be used in vaccines and immunogenic compositions. In addition, a method of determining that the inactivation of an arbovirus preparation has been completed.
ARP180103213A2017-11-032018-11-05
METHODS TO DEACTIVATE A ZIKA VIRUS AND TO DETERMINE TOTAL DEACTIVATION
AR113831A1
(en)
Adjuvant composition comprising a carbohydrate attached to the chitosan forming a schiff base; vaccine formulation that comprises it; elaboration method; and use of the vaccine.
A composition of an immunostimulant product for farmed fish, a formulation comprising the composition, a method for preparing said composition, and use of the composition and formulation.